Morteza Lotfi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Morteza Lotfi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ali Rostami
Student Research Committee Tabriz University of Medical Sciences Tabriz Iran
1 shared publication - Amirreza Naseri
Student Research Committee Tabriz University of Medical Sciences Tabriz Iran
1 shared publication - Fatemeh Shakouri
Student Research Committee Tabriz University of Medical Sciences Tabriz Iran
1 shared publication - Mahnaz Talebi
Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran
1 shared publication - Sarvin Sanaie
Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 29 January 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71205
Association between Mediterranean Diet and Development of Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Given the conflicting evidence regarding the impact of adherence to the Mediterranean diet (MedDiet) on MS development and the lack of a systematic review on this topic, this study aimed to examine this association. Methods: Following the PRISMA and JBI methods, a search of electronic databases was conducted through PubMed, Embase, Web of Science, and Scopus up to March 2024. Clinical original studies assessing the association between the MedDiet adherence and MS development were included. Risk of bias was evaluated using JBI critical appraisal tools. Meta‐analyses were performed using CMA4 software. Results: Out of 202 screened records, eight studies, including five case‐control and three cohort studies, met the inclusion criteria. Retrospective evidence from three case‐control studies suggested that MedDiet adherence is associated with decreased odds of MS, whereas cohort studies showed no significant relationship. Based on the meta‐analysis, there was a significant association between high adherence to the MedDiet and reduced odds of MS (fixed‐effect OR: 0.275, 95% CI: 0.11‐0.72, p ‐value <0.01, least MedDiet adherence as the reference). Discussion: Although the meta‐analysis showed a significant inverse association between higher adherence to the MedDiet and the odds of MS, the overall body of evidence does not provide strong support for a preventive role of the MedDiet. Considering the limited number of included studies, the predominantly retrospective design, the high risk of bias in several studies, and the substantial observed heterogeneity, further well‐designed prospective studies are needed.
- 29 January 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (2) , e71205
Open AccessAssociation between Mediterranean Diet and Development of Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Given the conflicting evidence regarding the impact of adherence to the Mediterranean diet (MedDiet) on MS development and the lack of a systematic review on this topic, this study aimed to examine this association. Methods: Following the PRISMA and JBI methods, a search of electronic databases was conducted through PubMed, Embase, Web of Science, and Scopus up to March 2024. Clinical original studies assessing the association between the MedDiet adherence and MS development were included. Risk of bias was evaluated using JBI critical appraisal tools. Meta‐analyses were performed using CMA4 software. Results: Out of 202 screened records, eight studies, including five case‐control and three cohort studies, met the inclusion criteria. Retrospective evidence from three case‐control studies suggested that MedDiet adherence is associated with decreased odds of MS, whereas cohort studies showed no significant relationship. Based on the meta‐analysis, there was a significant association between high adherence to the MedDiet and reduced odds of MS (fixed‐effect OR: 0.275, 95% CI: 0.11‐0.72, p ‐value <0.01, least MedDiet adherence as the reference). Discussion: Although the meta‐analysis showed a significant inverse association between higher adherence to the MedDiet and the odds of MS, the overall body of evidence does not provide strong support for a preventive role of the MedDiet. Considering the limited number of included studies, the predominantly retrospective design, the high risk of bias in several studies, and the substantial observed heterogeneity, further well‐designed prospective studies are needed.